US Stock MarketDetailed Quotes

APYX Apyx Medical

Watchlist

1.445
+0.025+1.76%

Close Nov 22 16:00 ET

1.445
0.0000.00%

Post 20:01 ET

54.40MMarket Cap-1762P/E (TTM)

Apyx Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-220.13%-4.44M

10.78%-4.33M

-237.11%-6.34M

74.12%-5.25M

51.17%-2.21M

168.96%3.7M

17.37%-4.85M

58.37%-1.88M

-94.09%-20.28M

-2,216.82%-4.53M

Net income from continuing operations

-1.05%-4.72M

-546.32%-6.59M

-114.89%-7.59M

19.02%-18.85M

-58.68%-9.62M

19.33%-4.68M

81.30%-1.02M

40.82%-3.53M

-53.14%-23.28M

-201.74%-6.07M

Operating gains losses

-22.22%28K

--0

--20K

642.67%557K

321,400.00%3.21M

24.14%36K

----

56.25%75K

-200.00%-1K

Depreciation and amortization

-22.58%144K

3.31%156K

-22.66%157K

-22.25%692K

-24.75%152K

-13.89%186K

-38.87%151K

-9.78%203K

-1.44%890K

-11.79%202K

Other non cash items

39.11%249K

54.27%253K

276.12%252K

--632K

--222K

--179K

--164K

--67K

----

Change In working capital

-119.17%-1.24M

121.13%700K

-301.92%-315K

206.25%5.54M

637.71%2.25M

524.14%6.45M

-27.33%-3.31M

123.08%156K

-183.07%-5.22M

-346.47%-419K

-Change in receivables

-104.40%-308K

87.23%-291K

134.60%1.48M

97.07%3.97M

-1.99%-1.38M

517.37%7M

-229.36%-2.28M

32.63%630K

141.21%2.02M

21.27%-1.36M

-Change in inventory

366.92%355K

218.55%409K

-84.30%138K

126.20%1.46M

917.31%1.06M

94.65%-133K

87.75%-345K

336.93%879K

-94.75%-5.57M

111.86%104K

-Change in prepaid assets

80.66%-124K

146.45%425K

-71.91%241K

64.05%-188K

25,600.00%510K

-2,389.29%-641K

23.62%-915K

32.20%858K

-138.60%-523K

-100.15%-2K

-Change in payables and accrued expense

-626.82%-1.16M

-30.22%157K

1.76%-2.17M

126.38%301K

147.84%2.07M

211.68%220K

164.47%225K

-54.72%-2.21M

-125.08%-1.14M

-40.00%834K

Cash from discontinued investing activities

Operating cash flow

-220.13%-4.44M

10.78%-4.33M

-237.11%-6.34M

74.12%-5.25M

51.17%-2.21M

168.96%3.7M

17.37%-4.85M

58.37%-1.88M

-94.09%-20.28M

-2,216.82%-4.53M

Investing cash flow

Cash flow from continuing investing activities

12.07%-153K

-104.06%-289K

68.18%-35K

766.73%6.73M

34.51%-93K

7.45%-174K

1,873.32%7.11M

60.57%-110K

-39.70%-1.01M

57.23%-142K

Net PPE purchase and sale

12.07%-153K

-104.06%-289K

68.18%-35K

766.73%6.73M

34.51%-93K

7.45%-174K

1,873.32%7.11M

60.57%-110K

-39.70%-1.01M

57.23%-142K

Cash from discontinued investing activities

Investing cash flow

12.07%-153K

-104.06%-289K

68.18%-35K

766.73%6.73M

34.51%-93K

7.45%-174K

1,873.32%7.11M

60.57%-110K

-39.70%-1.01M

57.23%-142K

Financing cash flow

Cash flow from continuing financing activities

-103.05%-5K

-110.87%-5K

-100.06%-5K

14,723.04%32.17M

238,540.00%23.84M

29.13%164K

2,200.00%46K

8,177.55%8.11M

804.17%217K

74.36%-10K

Net issuance payments of debt

99.17%-5K

50.00%-5K

-100.05%-5K

23,775.00%35.04M

257,920.00%25.78M

-1,896.67%-599K

81.48%-10K

18,370.37%9.87M

37.82%-148K

82.46%-10K

Proceeds from stock option exercised by employees

--0

----

-76.44%86K

---586K

292.36%616K

----

444.78%365K

--0

Net other financing activities

----

---2.96M

---1.35M

--147K

--0

---1.75M

----

Cash from discontinued financing activities

Financing cash flow

-103.05%-5K

-110.87%-5K

-100.06%-5K

14,723.04%32.17M

238,540.00%23.84M

29.13%164K

2,200.00%46K

8,177.55%8.11M

804.17%217K

74.36%-10K

Net cash flow

Beginning cash position

76.84%32.68M

129.36%37.28M

328.30%43.65M

-66.98%10.19M

49.22%22.13M

-7.90%18.48M

-38.04%16.26M

-66.98%10.19M

-26.35%30.87M

-51.99%14.83M

Current changes in cash

-224.74%-4.6M

-300.56%-4.62M

-204.25%-6.38M

259.69%33.65M

560.04%21.54M

167.99%3.69M

136.76%2.31M

230.26%6.12M

-89.03%-21.07M

-2,882.17%-4.68M

Effect of exchange rate changes

-116.13%-67K

123.46%19K

118.97%11K

-148.35%-191K

-151.22%-21K

-116.23%-31K

-181.00%-81K

-192.06%-58K

283.50%395K

-68.22%41K

End cash Position

26.56%28.01M

76.84%32.68M

129.36%37.28M

328.30%43.65M

49.22%22.13M

-7.90%18.48M

-38.04%16.26M

-66.98%10.19M

Free cash flow

-230.41%-4.59M

7.79%-4.62M

-220.24%-6.38M

72.84%-5.78M

50.66%-2.31M

163.48%3.52M

20.17%-5.01M

58.49%-1.99M

-90.57%-21.29M

-3,859.32%-4.67M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-220.13%-4.44M	10.78%-4.33M	-237.11%-6.34M	74.12%-5.25M	51.17%-2.21M	168.96%3.7M	17.37%-4.85M	58.37%-1.88M	-94.09%-20.28M	-2,216.82%-4.53M
Net income from continuing operations	-1.05%-4.72M	-546.32%-6.59M	-114.89%-7.59M	19.02%-18.85M	-58.68%-9.62M	19.33%-4.68M	81.30%-1.02M	40.82%-3.53M	-53.14%-23.28M	-201.74%-6.07M
Operating gains losses	-22.22%28K	--0	--20K	642.67%557K	321,400.00%3.21M	24.14%36K	----	----	56.25%75K	-200.00%-1K
Depreciation and amortization	-22.58%144K	3.31%156K	-22.66%157K	-22.25%692K	-24.75%152K	-13.89%186K	-38.87%151K	-9.78%203K	-1.44%890K	-11.79%202K
Other non cash items	39.11%249K	54.27%253K	276.12%252K	--632K	--222K	--179K	--164K	--67K	----	----
Change In working capital	-119.17%-1.24M	121.13%700K	-301.92%-315K	206.25%5.54M	637.71%2.25M	524.14%6.45M	-27.33%-3.31M	123.08%156K	-183.07%-5.22M	-346.47%-419K
-Change in receivables	-104.40%-308K	87.23%-291K	134.60%1.48M	97.07%3.97M	-1.99%-1.38M	517.37%7M	-229.36%-2.28M	32.63%630K	141.21%2.02M	21.27%-1.36M
-Change in inventory	366.92%355K	218.55%409K	-84.30%138K	126.20%1.46M	917.31%1.06M	94.65%-133K	87.75%-345K	336.93%879K	-94.75%-5.57M	111.86%104K
-Change in prepaid assets	80.66%-124K	146.45%425K	-71.91%241K	64.05%-188K	25,600.00%510K	-2,389.29%-641K	23.62%-915K	32.20%858K	-138.60%-523K	-100.15%-2K
-Change in payables and accrued expense	-626.82%-1.16M	-30.22%157K	1.76%-2.17M	126.38%301K	147.84%2.07M	211.68%220K	164.47%225K	-54.72%-2.21M	-125.08%-1.14M	-40.00%834K
Cash from discontinued investing activities
Operating cash flow	-220.13%-4.44M	10.78%-4.33M	-237.11%-6.34M	74.12%-5.25M	51.17%-2.21M	168.96%3.7M	17.37%-4.85M	58.37%-1.88M	-94.09%-20.28M	-2,216.82%-4.53M
Investing cash flow
Cash flow from continuing investing activities	12.07%-153K	-104.06%-289K	68.18%-35K	766.73%6.73M	34.51%-93K	7.45%-174K	1,873.32%7.11M	60.57%-110K	-39.70%-1.01M	57.23%-142K
Net PPE purchase and sale	12.07%-153K	-104.06%-289K	68.18%-35K	766.73%6.73M	34.51%-93K	7.45%-174K	1,873.32%7.11M	60.57%-110K	-39.70%-1.01M	57.23%-142K
Cash from discontinued investing activities
Investing cash flow	12.07%-153K	-104.06%-289K	68.18%-35K	766.73%6.73M	34.51%-93K	7.45%-174K	1,873.32%7.11M	60.57%-110K	-39.70%-1.01M	57.23%-142K
Financing cash flow
Cash flow from continuing financing activities	-103.05%-5K	-110.87%-5K	-100.06%-5K	14,723.04%32.17M	238,540.00%23.84M	29.13%164K	2,200.00%46K	8,177.55%8.11M	804.17%217K	74.36%-10K
Net issuance payments of debt	99.17%-5K	50.00%-5K	-100.05%-5K	23,775.00%35.04M	257,920.00%25.78M	-1,896.67%-599K	81.48%-10K	18,370.37%9.87M	37.82%-148K	82.46%-10K
Proceeds from stock option exercised by employees	--0	----	----	-76.44%86K	---586K	292.36%616K	----	----	444.78%365K	--0
Net other financing activities	----	----	----	---2.96M	---1.35M	--147K	--0	---1.75M	----	----
Cash from discontinued financing activities
Financing cash flow	-103.05%-5K	-110.87%-5K	-100.06%-5K	14,723.04%32.17M	238,540.00%23.84M	29.13%164K	2,200.00%46K	8,177.55%8.11M	804.17%217K	74.36%-10K
Net cash flow
Beginning cash position	76.84%32.68M	129.36%37.28M	328.30%43.65M	-66.98%10.19M	49.22%22.13M	-7.90%18.48M	-38.04%16.26M	-66.98%10.19M	-26.35%30.87M	-51.99%14.83M
Current changes in cash	-224.74%-4.6M	-300.56%-4.62M	-204.25%-6.38M	259.69%33.65M	560.04%21.54M	167.99%3.69M	136.76%2.31M	230.26%6.12M	-89.03%-21.07M	-2,882.17%-4.68M
Effect of exchange rate changes	-116.13%-67K	123.46%19K	118.97%11K	-148.35%-191K	-151.22%-21K	-116.23%-31K	-181.00%-81K	-192.06%-58K	283.50%395K	-68.22%41K
End cash Position	26.56%28.01M	76.84%32.68M	129.36%37.28M	328.30%43.65M	328.30%43.65M	49.22%22.13M	-7.90%18.48M	-38.04%16.26M	-66.98%10.19M	-66.98%10.19M
Free cash flow	-230.41%-4.59M	7.79%-4.62M	-220.24%-6.38M	72.84%-5.78M	50.66%-2.31M	163.48%3.52M	20.17%-5.01M	58.49%-1.99M	-90.57%-21.29M	-3,859.32%-4.67M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data